FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16178311000001102: Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57119601000001115 Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57119701000001113 Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Is a Dydrogesterone 5mg / Estradiol 1mg tablets true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has active ingredient Dydrogesterone true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has active ingredient Estradiol true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has specific active ingredient Dydrogesterone true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has specific active ingredient Estradiol true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Is a Femoston-conti true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) 84 tablet Has AMP True Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start